NewsBenzingaHC Wainwright & Co. maintient sa recommandation d’achat sur Revolution Medicines et relève son objectif de cours à 350 $ HC Wainwright & Co. maintient sa recommandation d’achat sur Revolution Medicines et relève son objectif de cours à 350 $ Benzinga 2026.11.06 12:13 (GMT+0) Open on Benzinga Other news Needham Maintains Buy on Genpact, Raises Price Target to $55 Anthropic IPO Valuation Range Revealed; HSBC Says Its Impact May Be Bigger Than the Midterms This Strategic Education Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday These Analysts Lower Their Forecasts On Alpha And Omega Semiconductor Following Q1 Results Reported Earlier: 'Protesters enter Microsoft data centre site in Amsterdam' - Reuters Needham Maintains Buy on Celsius Holdings, Raises Price Target to $40
